• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Coronary artery cannulation after transcatheter aortic valve implantation.经导管主动脉瓣植入术后的冠状动脉插管。
EuroIntervention. 2021 Nov 19;17(10):835-847. doi: 10.4244/EIJ-D-21-00158.
2
Functional Assessment of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation: Influence of Pressure Overload on the Evaluation of Lesions Severity.经导管主动脉瓣植入术患者冠状动脉疾病的功能评估:压力超负荷对病变严重程度评估的影响
Circ Cardiovasc Interv. 2016 Nov;9(11). doi: 10.1161/CIRCINTERVENTIONS.116.004088.
3
Transcatheter aortic valve implantation in patients with anomalous origin of a coronary artery.冠状动脉起源异常患者的经导管主动脉瓣植入术。
Catheter Cardiovasc Interv. 2023 Dec;102(7):1393-1400. doi: 10.1002/ccd.30860. Epub 2023 Oct 23.
4
Coronary Catheterization and Percutaneous Interventions After Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术后的冠状动脉导管插入术和经皮介入治疗
Am J Cardiol. 2017 Aug 15;120(4):625-631. doi: 10.1016/j.amjcard.2016.10.046. Epub 2016 Nov 16.
5
Feasibility of transcatheter aortic valve implantation in patients with coronary heights ≤7 mm: insights from the transcatheter aortic valve implantation Karlsruhe (TAVIK) registry.经导管主动脉瓣植入术在冠状动脉高度≤7mm 患者中的可行性:来自经导管主动脉瓣植入术卡尔斯鲁厄(TAVIK)注册研究的结果。
Eur J Cardiothorac Surg. 2018 Oct 1;54(4):752-761. doi: 10.1093/ejcts/ezy130.
6
Coronary Access and Percutaneous Coronary Intervention Up to 3 Years After Transcatheter Aortic Valve Implantation With a Balloon-Expandable Valve.经皮球囊扩张式主动脉瓣置换术后 3 年内的冠状动脉入路和经皮冠状动脉介入治疗。
Circ Cardiovasc Interv. 2020 Jul;13(7):e008972. doi: 10.1161/CIRCINTERVENTIONS.120.008972. Epub 2020 Jun 25.
7
Physiologic evaluation of coronary lesions using instantaneous wave-free ratio (iFR) in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation.应用瞬时无波比(iFR)评价严重主动脉瓣狭窄患者行经导管主动脉瓣植入术后的冠状动脉病变。
EuroIntervention. 2018 Jan 20;13(13):1512-1519. doi: 10.4244/EIJ-D-17-00542.
8
Coronary Cannulation After Transcatheter Aortic Valve Replacement: The RE-ACCESS Study.经导管主动脉瓣置换术后的冠状动脉插管:RE-ACCESS 研究。
JACC Cardiovasc Interv. 2020 Nov 9;13(21):2542-2555. doi: 10.1016/j.jcin.2020.07.006. Epub 2020 Oct 14.
9
A novel high-risk aortic root anatomy for right coronary artery occlusion during TAVI.经导管主动脉瓣植入术(TAVI)期间右冠状动脉闭塞的一种新型高风险主动脉根部解剖结构。
Catheter Cardiovasc Interv. 2023 Dec;102(7):1389-1392. doi: 10.1002/ccd.30883. Epub 2023 Oct 27.
10
Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.经导管主动脉瓣植入术(TAVI)的极简方法:开放血管法与完全经皮法
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2019 Oct 1;40(2):5-14. doi: 10.2478/prilozi-2019-0009.

引用本文的文献

1
The TAVI Dilemma: Balloon-Expandable or Self-Expanding Transcatheter Heart Valve-Interpreting Current Evidence for Personalized Valve Selection.经导管主动脉瓣置入术的困境:球囊扩张式与自膨胀式经导管心脏瓣膜——解读个性化瓣膜选择的当前证据
J Clin Med. 2025 Aug 9;14(16):5651. doi: 10.3390/jcm14165651.
2
Co-Occurrence of Aortic Stenosis and Coronary Artery Disease: Facing Challenges Before, During, and After Transcatheter Aortic Valve Replacement.主动脉瓣狭窄与冠状动脉疾病的共病:经导管主动脉瓣置换术前、术中和术后面临的挑战
J Clin Med. 2025 Jul 3;14(13):4709. doi: 10.3390/jcm14134709.
3
Multimodality Imaging for Facilitating Percutaneous Coronary Intervention of a Calcified Nodule Post Redo TAVR.多模态成像辅助经皮冠状动脉介入治疗再次经导管主动脉瓣置换术后钙化结节
JACC Case Rep. 2025 Jun 25;30(16):104013. doi: 10.1016/j.jaccas.2025.104013.
4
Transcatheter Aortic Valve Implantation Indications and Patient Selection.经导管主动脉瓣植入术的适应症及患者选择
Interv Cardiol. 2025 Jun 10;20:e19. doi: 10.15420/icr.2024.44. eCollection 2025.
5
Unravelling the Fate of Coronary Artery Disease in Patients Undergoing Valve Replacement for Severe Aortic Valve Stenosis.探究重度主动脉瓣狭窄患者行瓣膜置换术后冠状动脉疾病的转归
Rev Cardiovasc Med. 2023 Feb 23;24(3):68. doi: 10.31083/j.rcm2403068. eCollection 2023 Mar.
6
Characterization and Management of Stable Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术患者中稳定性冠状动脉疾病的特征与管理
J Clin Med. 2024 Jun 14;13(12):3497. doi: 10.3390/jcm13123497.
7
Ultra-low radiation dose and contrast volume CT protocol and TAVI-CT score for TAVI planning and outcome.用于 TAVI 规划和结果的超低辐射剂量和对比剂体积 CT 方案以及 TAVI-CT 评分。
Br J Radiol. 2023 Aug;96(1148):20221026. doi: 10.1259/bjr.20221026. Epub 2023 May 15.
8
Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery.经导管主动脉瓣植入术患者的冠状动脉疾病管理。欧洲经皮心血管介入协会与 ESC 心血管外科学工作组合作的临床共识声明。
EuroIntervention. 2023 May 15;19(1):37-52. doi: 10.4244/EIJ-D-22-00958.
9
Coronary access after ACURATE neo2 implantation for valve-in-valve TAVR: Insights from ex vivo simulations.ACURATE neo2植入后用于瓣中瓣经导管主动脉瓣置换术的冠状动脉通路:来自体外模拟的见解
Catheter Cardiovasc Interv. 2022 Oct;100(4):662-666. doi: 10.1002/ccd.30367. Epub 2022 Sep 18.
10
Coronary access techniques following ACURATE neo2 implantation in surgical bioprosthesis.在外科生物假体中植入ACURATE neo2后冠状动脉接入技术。
EuroIntervention. 2022 Nov 18;18(10):820-821. doi: 10.4244/EIJ-D-22-00149.

本文引用的文献

1
ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical Trial.经皮冠状动脉介入治疗在前瞻性经导管主动脉瓣植入术之前的作用:一项随机临床试验。
JACC Cardiovasc Interv. 2021 Sep 27;14(18):1965-1974. doi: 10.1016/j.jcin.2021.06.041.
2
Patient-Specific Implantation Technique to Obtain Neo-Commissural Alignment With Self-Expanding Transcatheter Aortic Valves.患者特异性植入技术实现自膨式经导管主动脉瓣的新交界对位。
JACC Cardiovasc Interv. 2021 Oct 11;14(19):2097-2108. doi: 10.1016/j.jcin.2021.06.033. Epub 2021 Sep 15.
3
Transcatheter aortic valve neo-commissure alignment with the Portico system.经导管主动脉瓣新交界与Portico系统的对齐
EuroIntervention. 2021 Jun 11;17(2):e152-e155. doi: 10.4244/EIJ-D-20-01095.
4
Risk of Coronary Obstruction and Feasibility of Coronary Access After Repeat Transcatheter Aortic Valve Replacement With the Self-Expanding Evolut Valve: A Computed Tomography Simulation Study.经皮主动脉瓣置换术后重复使用自膨式 Evolut 瓣膜的冠状动脉阻塞风险和冠状动脉入路的可行性:计算机断层扫描模拟研究。
Circ Cardiovasc Interv. 2020 Dec;13(12):e009496. doi: 10.1161/CIRCINTERVENTIONS.120.009496. Epub 2020 Dec 4.
5
Coronary Access After TAVR-in-TAVR as Evaluated by Multidetector Computed Tomography.经多排螺旋计算机断层扫描评估的 TAVR 内再 TAVR 后的冠状动脉入路
JACC Cardiovasc Interv. 2020 Nov 9;13(21):2528-2538. doi: 10.1016/j.jcin.2020.06.016.
6
Coronary Cannulation After Transcatheter Aortic Valve Replacement: The RE-ACCESS Study.经导管主动脉瓣置换术后的冠状动脉插管:RE-ACCESS 研究。
JACC Cardiovasc Interv. 2020 Nov 9;13(21):2542-2555. doi: 10.1016/j.jcin.2020.07.006. Epub 2020 Oct 14.
7
A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation.经导管主动脉瓣置换术后再次行经皮冠状动脉介入治疗时的冠状动脉入路和冠状动脉阻塞的计算机断层扫描研究。
EuroIntervention. 2020 Dec 18;16(12):e1005-e1013. doi: 10.4244/EIJ-D-20-00475.
8
ACURATE neo: How Is This TAVR Valve Doing to Fit into an Increasingly Crowded Field?ACURATE neo:这款经导管主动脉瓣置换术瓣膜在日益拥挤的领域表现如何?
Curr Cardiol Rep. 2020 Aug 8;22(10):107. doi: 10.1007/s11886-020-01364-4.
9
Myval transcatheter heart valve system in the treatment of severe symptomatic aortic stenosis.Myval 经导管心脏瓣膜系统治疗重度症状性主动脉瓣狭窄
Future Cardiol. 2021 Jan;17(1):73-80. doi: 10.2217/fca-2020-0020. Epub 2020 Jul 6.
10
Coronary Angiography After Transcatheter Aortic Valve Replacement (TAVR) to Evaluate the Risk of Coronary Access Impairment After TAVR-in-TAVR.经导管主动脉瓣置换术(TAVR)后行冠状动脉造影评估 TAVR 中再 TAVR 后冠状动脉入路受损的风险。
J Am Heart Assoc. 2020 Jul 7;9(13):e016446. doi: 10.1161/JAHA.120.016446. Epub 2020 Jun 24.

经导管主动脉瓣植入术后的冠状动脉插管。

Coronary artery cannulation after transcatheter aortic valve implantation.

机构信息

Division of Cardiology, A.O.U. Policlinico "G. Rodolico-San Marco", Catania, Italy.

出版信息

EuroIntervention. 2021 Nov 19;17(10):835-847. doi: 10.4244/EIJ-D-21-00158.

DOI:10.4244/EIJ-D-21-00158
PMID:34796879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9724942/
Abstract

Transcatheter aortic valve implantation (TAVI) has revolutionised the treatment of severe, symptomatic aortic stenosis and it is now a proven and effective alternative to surgery for patients regardless of preoperative risk stratification. Nevertheless, the consequent expansion towards younger patients with longer life expectancy focuses attention on long-term considerations. In particular, although the prevalence of coronary artery disease has been shown to decrease with the lowering of estimated risk stratification, the chance of requirement of future coronary interventions after TAVI increases dramatically as a function of patients' life expectancy. To date, however, only a few studies have investigated the feasibility and reproducibility of coronary artery cannulation after TAVI. Different conditions related mainly to aortic root anatomy and specific transcatheter aortic valve (TAV) designs and deployment have been associated with impaired coronary access after TAVI. In the present review, we will examine the conditions that may make coronary access after TAVI more challenging or even impossible.

摘要

经导管主动脉瓣植入术(TAVI)已经彻底改变了严重、有症状的主动脉瓣狭窄的治疗方法,现在无论术前风险分层如何,它都是手术的一种成熟且有效的替代方法。然而,随之而来的向预期寿命更长的年轻患者扩展的趋势,使得人们更加关注长期考虑因素。特别是,虽然已经证明随着风险分层估计值的降低,冠状动脉疾病的患病率会下降,但 TAVI 后未来冠状动脉介入治疗的需求几率会随着患者预期寿命的增加而急剧增加。然而,迄今为止,只有少数研究调查了 TAVI 后进行冠状动脉插管的可行性和可重复性。不同的情况主要与主动脉根部解剖结构以及特定的经导管主动脉瓣(TAV)设计和部署有关,这些情况与 TAVI 后冠状动脉通路受损有关。在本综述中,我们将探讨可能使 TAVI 后进行冠状动脉介入治疗更具挑战性甚至不可能的情况。